{"entity":{"type":"insider","cik":"0001563420","url":"/insider/0001563420","json_url":"/insider/0001563420.json","name":"LEDERMAN SETH","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":46,"n_filings":38,"first":"2013-05-20","last":"2026-06-09","span_basis":"filed_date"},"name_variants":[{"name":"LEDERMAN SETH","source":"filing","n_filings":38,"first_seen":"2013-05-20","last_seen":"2026-06-09"}],"transactions":[{"id":6021732,"accession":"0001493152-26-027986","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-027986","line_url":"/filing/0001493152-26-027986#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":11.79,"price_display":"11.79","price_state":"stated","total_value":58950.0,"total_display":"58,950.00","total_whole":"58,950","shares_owned_after":9005.0,"shares_owned_after_display":"9,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-09","filed_date":"2026-06-09","scope":"insider"},{"id":5938947,"accession":"0001999371-26-007447","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001999371-26-007447","line_url":"/filing/0001999371-26-007447#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":12.62,"price_display":"12.62","price_state":"stated","total_value":63100.0,"total_display":"63,100.00","total_whole":"63,100","shares_owned_after":20001.0,"shares_owned_after_display":"20,001","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-04-01","scope":"insider"},{"id":5780075,"accession":"0001999371-26-006235","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001999371-26-006235","line_url":"/filing/0001999371-26-006235#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":14.89,"price_display":"14.89","price_state":"stated","total_value":223350.0,"total_display":"223,350.00","total_whole":"223,350","shares_owned_after":15001.0,"shares_owned_after_display":"15,001","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-18","scope":"insider"},{"id":4745072,"accession":"0001999371-25-006261","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001999371-25-006261","line_url":"/filing/0001999371-25-006261#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":21.55,"price_display":"21.55","price_state":"stated","total_value":86200.0,"total_display":"86,200.00","total_whole":"86,200","shares_owned_after":4005.0,"shares_owned_after_display":"4,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-15","filed_date":"2025-05-15","scope":"insider"},{"id":6338961,"accession":"0001387131-22-007441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-22-007441","line_url":"/filing/0001387131-22-007441#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.71,"price_display":"1.71","price_state":"stated","total_value":34200.0,"total_display":"34,200.00","total_whole":"34,200","shares_owned_after":24235.0,"shares_owned_after_display":"24,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-29","filed_date":"2022-07-01","scope":"insider"},{"id":6363123,"accession":"0001387131-22-003991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-22-003991","line_url":"/filing/0001387131-22-003991#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.245,"price_display":"0.24","price_state":"stated","total_value":24500.0,"total_display":"24,500.00","total_whole":"24,500","shares_owned_after":112177.0,"shares_owned_after_display":"112,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-25","filed_date":"2022-03-28","scope":"insider"},{"id":5545135,"accession":"0001387131-21-009696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-21-009696","line_url":"/filing/0001387131-21-009696#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":0.61,"price_display":"0.61","price_state":"stated","total_value":7320.0,"total_display":"7,320.00","total_whole":"7,320","shares_owned_after":12177.0,"shares_owned_after_display":"12,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-28","filed_date":"2021-09-28","scope":"insider"},{"id":4754113,"accession":"0001387131-21-003875","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-21-003875","line_url":"/filing/0001387131-21-003875#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16733.0,"shares_display":"16,733","price_per_share":1.32,"price_display":"1.32","price_state":"stated","total_value":22087.56,"total_display":"22,087.56","total_whole":"22,088","shares_owned_after":135000.0,"shares_owned_after_display":"135,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-24","filed_date":"2021-03-25","scope":"insider"},{"id":5021857,"accession":"0001387131-21-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-21-000041","line_url":"/filing/0001387131-21-000041#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":23800.0,"total_display":"23,800.00","total_whole":"23,800","shares_owned_after":118267.0,"shares_owned_after_display":"118,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-30","filed_date":"2021-01-04","scope":"insider"},{"id":2235149,"accession":"0001387131-20-007592","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-20-007592","line_url":"/filing/0001387131-20-007592#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":54600.0,"total_display":"54,600.00","total_whole":"54,600","shares_owned_after":83267.0,"shares_owned_after_display":"83,267","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-13","filed_date":"2020-08-17","scope":"insider"},{"id":7957208,"accession":"0001387131-19-009327","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-19-009327","line_url":"/filing/0001387131-19-009327#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.159,"price_display":"1.16","price_state":"stated","total_value":23180.0,"total_display":"23,180.00","total_whole":"23,180","shares_owned_after":23267.0,"shares_owned_after_display":"23,267","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-03","filed_date":"2019-12-04","scope":"insider"},{"id":8528714,"accession":"0001387131-19-002339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-19-002339","line_url":"/filing/0001387131-19-002339#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.488,"price_display":"2.49","price_state":"stated","total_value":12440.0,"total_display":"12,440.00","total_whole":"12,440","shares_owned_after":32670.0,"shares_owned_after_display":"32,670","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-29","filed_date":"2019-04-01","scope":"insider"},{"id":8014608,"accession":"0001387131-19-002230","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-19-002230","line_url":"/filing/0001387131-19-002230#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.375,"price_display":"2.38","price_state":"stated","total_value":59375.0,"total_display":"59,375.00","total_whole":"59,375","shares_owned_after":27670.0,"shares_owned_after_display":"27,670","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-26","filed_date":"2019-03-28","scope":"insider"},{"id":6709806,"accession":"0001615774-18-006088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-18-006088","line_url":"/filing/0001615774-18-006088#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.64,"price_display":"4.64","price_state":"stated","total_value":2320.0,"total_display":"2,320.00","total_whole":"2,320","shares_owned_after":17666.0,"shares_owned_after_display":"17,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-29","filed_date":"2018-07-02","scope":"insider"},{"id":6030757,"accession":"0001615774-18-006006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-18-006006","line_url":"/filing/0001615774-18-006006#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.58,"price_display":"4.58","price_state":"stated","total_value":2290.0,"total_display":"2,290.00","total_whole":"2,290","shares_owned_after":17166.0,"shares_owned_after_display":"17,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-28","filed_date":"2018-06-29","scope":"insider"},{"id":6428975,"accession":"0001615774-18-005896","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-18-005896","line_url":"/filing/0001615774-18-005896#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.55,"price_display":"4.55","price_state":"stated","total_value":2275.0,"total_display":"2,275.00","total_whole":"2,275","shares_owned_after":16666.0,"shares_owned_after_display":"16,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2018-06-28","scope":"insider"},{"id":6319135,"accession":"0001615774-18-005290","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001615774-18-005290","line_url":"/filing/0001615774-18-005290","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":4.37,"price_display":"4.37","price_state":"stated","total_value":13110.0,"total_display":"13,110.00","total_whole":"13,110","shares_owned_after":20463.0,"shares_owned_after_display":"20,463","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-12","filed_date":"2018-06-14","scope":"insider","n_lines":2},{"id":6279457,"accession":"0001615774-18-004510","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-18-004510","line_url":"/filing/0001615774-18-004510#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":12680.0,"total_display":"12,680.00","total_whole":"12,680","shares_owned_after":26700.0,"shares_owned_after_display":"26,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-25","filed_date":"2018-05-30","scope":"insider"},{"id":5026779,"accession":"0001615774-17-007619","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-17-007619","line_url":"/filing/0001615774-17-007619#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5300.0,"shares_display":"5,300","price_per_share":3.61,"price_display":"3.61","price_state":"stated","total_value":19133.0,"total_display":"19,133.00","total_whole":"19,133","shares_owned_after":22700.0,"shares_owned_after_display":"22,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-26","filed_date":"2017-12-27","scope":"insider"},{"id":4421123,"accession":"0001615774-17-004563","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001615774-17-004563","line_url":"/filing/0001615774-17-004563#line-2","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":3.0045,"price_display":"3.00","price_state":"stated","total_value":45067.5,"total_display":"45,067.50","total_whole":"45,068","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-08-17","filed_date":"2017-08-18","scope":"insider"},{"id":4421118,"accession":"0001615774-17-004563","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-17-004563","line_url":"/filing/0001615774-17-004563#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.99,"price_display":"2.99","price_state":"stated","total_value":14950.0,"total_display":"14,950.00","total_whole":"14,950","shares_owned_after":35000.0,"shares_owned_after_display":"35,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-08-16","filed_date":"2017-08-18","scope":"insider"},{"id":4624403,"accession":"0001615774-17-003457","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-17-003457","line_url":"/filing/0001615774-17-003457#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.328,"price_display":"4.33","price_state":"stated","total_value":21640.0,"total_display":"21,640.00","total_whole":"21,640","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-30","filed_date":"2017-06-30","scope":"insider"},{"id":4980590,"accession":"0001615774-17-003376","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-17-003376","line_url":"/filing/0001615774-17-003376#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.3999,"price_display":"4.40","price_state":"stated","total_value":21999.5,"total_display":"21,999.50","total_whole":"22,000","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-26","filed_date":"2017-06-26","scope":"insider"},{"id":4156946,"accession":"0001615774-17-003262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-17-003262","line_url":"/filing/0001615774-17-003262#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":4.22,"price_display":"4.22","price_state":"stated","total_value":84400.0,"total_display":"84,400.00","total_whole":"84,400","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-20","filed_date":"2017-06-20","scope":"insider"},{"id":2573773,"accession":"0001615774-16-008539","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-16-008539","line_url":"/filing/0001615774-16-008539#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":98000.0,"shares_display":"98,000","price_per_share":0.4278,"price_display":"0.43","price_state":"stated","total_value":41924.4,"total_display":"41,924.40","total_whole":"41,924","shares_owned_after":133000.0,"shares_owned_after_display":"133,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-21","filed_date":"2016-11-22","scope":"insider"},{"id":2343445,"accession":"0001615774-16-007912","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-16-007912","line_url":"/filing/0001615774-16-007912#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":90815.0,"shares_owned_after_display":"90,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-31","filed_date":"2016-10-31","scope":"insider"},{"id":3054870,"accession":"0001615774-16-006035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-16-006035","line_url":"/filing/0001615774-16-006035#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.075,"price_display":"2.08","price_state":"stated","total_value":41500.0,"total_display":"41,500.00","total_whole":"41,500","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-22","filed_date":"2016-06-22","scope":"insider"},{"id":3340545,"accession":"0001615774-16-005996","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-16-005996","line_url":"/filing/0001615774-16-005996#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":31000.0,"shares_owned_after_display":"31,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-21","filed_date":"2016-06-21","scope":"insider"},{"id":3332611,"accession":"0001144204-16-089880","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-089880","line_url":"/filing/0001144204-16-089880#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":2.4421,"price_display":"2.44","price_state":"stated","total_value":19536.8,"total_display":"19,536.80","total_whole":"19,537","shares_owned_after":80815.0,"shares_owned_after_display":"80,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-23","filed_date":"2016-03-23","scope":"insider"},{"id":8501479,"accession":"0001144204-15-056504","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-056504","line_url":"/filing/0001144204-15-056504#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":39000.0,"total_display":"39,000.00","total_whole":"39,000","shares_owned_after":71074.0,"shares_owned_after_display":"71,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-25","filed_date":"2015-09-25","scope":"insider"},{"id":8527673,"accession":"0001144204-15-043102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-043102","line_url":"/filing/0001144204-15-043102#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":45000.0,"total_display":"45,000.00","total_whole":"45,000","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-17","filed_date":"2015-07-17","scope":"insider"},{"id":8402885,"accession":"0001144204-15-016666","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-016666","line_url":"/filing/0001144204-15-016666#line-2","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.18,"price_display":"7.18","price_state":"stated","total_value":7180.0,"total_display":"7,180.00","total_whole":"7,180","shares_owned_after":65074.0,"shares_owned_after_display":"65,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-17","filed_date":"2015-03-17","scope":"insider"},{"id":8402881,"accession":"0001144204-15-016666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-016666","line_url":"/filing/0001144204-15-016666#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.8533,"price_display":"6.85","price_state":"stated","total_value":6853.3,"total_display":"6,853.30","total_whole":"6,853","shares_owned_after":64074.0,"shares_owned_after_display":"64,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-16","filed_date":"2015-03-17","scope":"insider"},{"id":8364669,"accession":"0001144204-15-015878","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-015878","line_url":"/filing/0001144204-15-015878#line-2","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.21,"price_display":"7.21","price_state":"stated","total_value":7210.0,"total_display":"7,210.00","total_whole":"7,210","shares_owned_after":63074.0,"shares_owned_after_display":"63,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-13","filed_date":"2015-03-13","scope":"insider"},{"id":8364663,"accession":"0001144204-15-015878","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-015878","line_url":"/filing/0001144204-15-015878#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.26,"price_display":"7.26","price_state":"stated","total_value":7260.0,"total_display":"7,260.00","total_whole":"7,260","shares_owned_after":62074.0,"shares_owned_after_display":"62,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-12","filed_date":"2015-03-13","scope":"insider"},{"id":8810006,"accession":"0001144204-15-015317","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-015317","line_url":"/filing/0001144204-15-015317#line-2","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":7000.0,"total_display":"7,000.00","total_whole":"7,000","shares_owned_after":61074.0,"shares_owned_after_display":"61,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-11","filed_date":"2015-03-11","scope":"insider"},{"id":8810005,"accession":"0001144204-15-015317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-015317","line_url":"/filing/0001144204-15-015317#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.9,"price_display":"6.90","price_state":"stated","total_value":6900.0,"total_display":"6,900.00","total_whole":"6,900","shares_owned_after":60074.0,"shares_owned_after_display":"60,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-10","filed_date":"2015-03-11","scope":"insider"},{"id":8327133,"accession":"0001144204-15-014740","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-014740","line_url":"/filing/0001144204-15-014740#line-2","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":6500.0,"total_display":"6,500.00","total_whole":"6,500","shares_owned_after":59074.0,"shares_owned_after_display":"59,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-09","filed_date":"2015-03-09","scope":"insider"},{"id":8327129,"accession":"0001144204-15-014740","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-014740","line_url":"/filing/0001144204-15-014740#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.45,"price_display":"6.45","price_state":"stated","total_value":6450.0,"total_display":"6,450.00","total_whole":"6,450","shares_owned_after":58074.0,"shares_owned_after_display":"58,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-06","filed_date":"2015-03-09","scope":"insider"},{"id":8101124,"accession":"0001144204-15-014339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-014339","line_url":"/filing/0001144204-15-014339#line-2","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":6480.0,"total_display":"6,480.00","total_whole":"6,480","shares_owned_after":57074.0,"shares_owned_after_display":"57,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-05","scope":"insider"},{"id":8101120,"accession":"0001144204-15-014339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-014339","line_url":"/filing/0001144204-15-014339#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.05,"price_display":"6.05","price_state":"stated","total_value":6050.0,"total_display":"6,050.00","total_whole":"6,050","shares_owned_after":56074.0,"shares_owned_after_display":"56,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-04","filed_date":"2015-03-05","scope":"insider"},{"id":8791137,"accession":"0001144204-15-007164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-007164","line_url":"/filing/0001144204-15-007164#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.85,"price_display":"5.85","price_state":"stated","total_value":29250.0,"total_display":"29,250.00","total_whole":"29,250","shares_owned_after":55074.0,"shares_owned_after_display":"55,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-09","filed_date":"2015-02-09","scope":"insider"},{"id":5288255,"accession":"0001144204-13-046276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-046276","line_url":"/filing/0001144204-13-046276#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11765.0,"shares_display":"11,765","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":50074.0,"shares_owned_after_display":"50,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-14","filed_date":"2013-08-15","scope":"insider"},{"id":5351270,"accession":"0001144204-13-030431","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-13-030431","line_url":"/filing/0001144204-13-030431","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563420","owner_name":"LEDERMAN SETH","owner_display_name":"LEDERMAN SETH","owner_url":"/insider/0001563420","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.3,"price_display":"7.30","price_state":"stated","total_value":7300.0,"total_display":"7,300.00","total_whole":"7,300","shares_owned_after":37909.0,"shares_owned_after_display":"37,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-20","filed_date":"2013-05-20","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":46,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":46,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":46},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001430306","name":"Tonix Pharmaceuticals Holding Corp.","url":"/issuer/0001430306","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":38,"first_seen":"2013-05-20","last_seen":"2026-06-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001563420","retrieved_at":"2026-08-26T07:21:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}